Alzheimer's disease, Parkinson's disease and other neurodegenerative illnesses are typical CNS disorders requiring blood-brain barrier penetrating delivery systems for siRNA therapeutics. Youngen's CEREBRO SHUTTLE™ delivery platform delivers therapeutics to neurons and glial cells with potent efficacy and an excellent safety profile. Precision neurology targets root disease-driving genetic aberrations within central nervous system tissue.
